Status:
UNKNOWN
Trajectories of Fatigue and Quality of Life in People With Both Operable Pancreatic Tumor and Diabetes Mellitus
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Operable Pancreatic Tumor
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Brief Summary
In people with both burdens of OPT and DM, fatigue is the most common and deliberating symptom that likely impacts their quality of life and diabetes self-management. However, little is known about th...
Detailed Description
Pancreatic cancer is a devastating disease, and surgery is one of the treatment options with the goal of curing the disease. However, people with operable pancreatic tumor (OPT) often have a high prev...
Eligibility Criteria
Inclusion
- Operable pancreatic tumor within 5 years and are following up at the outpatient department
- Diagnosed with diabetes mellitus
- Aged 18 or above
- Can communicate in Mandarin or Taiwanese
- Agree to participate and sign the informed consent form
Exclusion
- Under active treatment for cancer other than pancreatic tumor
- Have a cognitive impairment
- Do not know that they have pancreatic tumor
- Diagnosed with chronic fatigue syndrome or fibromyalgia
Key Trial Info
Start Date :
August 30 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
115 Patients enrolled
Trial Details
Trial ID
NCT06013228
Start Date
August 30 2023
End Date
July 31 2025
Last Update
January 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan